An Updated Meta-Analysis of Randomized Controlled Trials Assessing the Effect of Sorafenib in Advanced Hepatocellular Carcinoma

Open Access

Peer-reviewed

Research Article

Songlin Peng,

Affiliation Department of Hepatobiliary Surgery, The Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, China
⨯
Yang Zhao,

Affiliation Department of Hepatobiliary Surgery, The Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, China
⨯
Feng Xu,

Affiliation Department of Hepatobiliary Surgery, The Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, China
⨯
Changjun Jia,

Affiliation Department of Hepatobiliary Surgery, The Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, China
⨯
Yongqing Xu,

Affiliation Department of Hepatobiliary Surgery, The Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, China
⨯
Chaoliu Dai

* E-mail: daicl@sj-hospital.org

Affiliation Department of Hepatobiliary Surgery, The Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, China
⨯

Reader Comments (0)

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Database searching
Is the Subject Area "Database searching" applicable to this article?

Thanks for your feedback.
Hepatitis B virus
Is the Subject Area "Hepatitis B virus" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.